Skeletal effects of growth hormone and IGF-I in adults

Hormone Research in Paediatrics

Volumn 48, Issue 5, 1997, Pages 60-64

  Marcus, Robert ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adults; Growth hormone; IGF I; Skeletal effects

Indexed keywords

GROWTH HORMONE; SOMATOMEDIN C;

ARTIFACT; BONE ATROPHY; BONE DENSITY; BONE GROWTH; BONE MASS; BONE MINERAL; BONE REMODELING; CONFERENCE PAPER; DUAL ENERGY X RAY ABSORPTIOMETRY; FRACTURE HEALING; HIP; HORMONAL THERAPY; HUMAN; LUMBAR SPINE; OSSIFICATION; OSTEOLYSIS; OSTEOPOROSIS; PRIORITY JOURNAL; SKELETON;

ADULT; BONE DEVELOPMENT; FEMALE; GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MALE;

EID: 0030777475     PISSN: 16632818     EISSN: 16632826     Source Type: Journal    
DOI: 10.1159/000191330     Document Type: Article

References (38)

1. Rudman D: Growth hormone, body composition, and ageing. J Am Geriatr Soc 1985:33: 800-807.
2. Dequeker J, Nijs J, Verstraeten A, Geuscns P, Gevcrs G: Genetic determinants of bone mineral content at the spine and radius: A twin study. Bone 1987;8:207-209.
3. Seeman E, Hopper JL, Bach L.A, Cooper ME, Parkinson E, McKay J, Jercns G: Reduced bone mass in daughtersof women in osteoporosis. N Engl J Med 1988;320:554-558.
4. Marcus R, Carter DR: The role of physical activity in bone mass regulation. Adv Sports Med Fitness 1988;1:63-82.
5. Marcus R: Calcium intake and skeletal integrity: is there a critical relationship? J Nutr 1987; 117:631-635.
6. Longcopc C, Baker RS, Hui SL, Johnston CC Jr: Androgen and estrogen dynamics in women with vertebral crush fractures. Maturitas 1985: 6:309-318.
7. Lindsav R, Hart DM, Forrest C, Baird C: Prevention of spinal osteoporosis in oophorectom-iscdwomen.Lancet 1980:ii: 1151-1154.
8. Tilvard MW, Spears GFS, Thomson J, Dovev S: Treatment of postmenopausal osteoporosis with ealcitriol or calcium. N Engl.1 Med 1992; 326:357-362.
9. Black F, Cummings SR, Karpf DB, Cauley JA, Thompson DE, Nevitt MC, Genanl UK, Haskell WL, Marcus R, Ott SM, Tomer JC, Quandt SA, Reiss TF, Ensrud KE, For the Fracture Intervention Trial Research Group: Alendronate reduces the risk of fractures in women with existing vertebral fractures: results of the Fracture Intervention Trial. Lancet 1996:348: 1535-1541.
10. Slracke H, Schultz A, Moeller D, Rossol S, Schatz H: Effect of growth hormone on osteoblasts and demonstration of somatomedin C/ IGF-1 in bone organ culture. Acta Endocrinol (Copenh) 1984:107:16-24.
11. Chenu C, Valentin-Opran A, Chavassieux R, Saez S, Meunier PJ, Delmas PD: Insulin like growth factor I hormonal regulation by growth hormone and by l,25(OH)D3 and activity on human osteoblast-like cells in short-term cultures. Bone 1990;11:81-86.
12. Barnard R, Ng KW, Martin TJ, Waters MJ: Growth hormone (GH) receptors in clonal osteoblast-like cells mediate a mitogenic response toGH. Endocrinol 1991;128:1459-1464.
13. Harris WH, Heaney RP: Effect of growth hormone on skeletal mass in adult dogs. Nature 1969;273:403-404.
14. Mann DR, Rudman CG, Akinbami MA, Gould KG: Preservation ofbone mass in hypo-gonadal female monkeys with recombinant hu man growth hormone administration. J Clin Endocrinol Metab 1992:74:1263-1269.
15. Marcus R: Normal and abnormal bone remodelling in man. Ann Rev Med 1987;38:129-141.
16. Rosen T, Hansson T, Granhed H, Szucs J, Bengtsson BA: Reduced bone mineral content in adult patients with growth hormone deficiency. Acta Endocrinol (Copenh) 1993; 129: 201-206.
17. Bing-You RG, Denis MC, Rosen CJ: Low bone mineral density in adults with previous hypo-thalamic-pituitary tumors: correlations with serum growth hormone response to GH-releasing hormone, insulin-like growth factor I. and IGF binding protein 3. CalcifTiss Int 1993:52:183-187.
18. Holmes SJ, Economou G, Whitehouse RW, Adams JE, Shalel SM: Reduced bone mineral density in patients with adult onset growth hormone deficiency. J Clin Endocrinol Metab 1994:78:669-674.
19. Johansson AG, Burman P, Westermark K, Ljunghall S: The bone mineral density in acquired growth hormone deficiency correlates with circulating levels of insulin-like growth factor I. J Intern Med 1992:232:447-452.
20. O'Halloran DJ, Tsatsoulis A, Whitehouse RW, Holmes SJ, Adams JE, Shalct SM: Increased bone density after recombinant human growth hormone therapy in adults with isolated GH deficiency. J Clin Endocrinol Metab 1993:76: 1344-1348.
21. Hyer SL, Rodin DA, Tobias JH, Leiper A, Nus-scy SS: Growth hormone deficiency during puberty reduces adult bone mineral density. Arch Dis Child 1992;67:1472-1474.
22. DeBoer H, Blok GJ, VanLingen A, Teule GJ, Lips P, van der Veen EA: Consequences of childhood-onsel growth hormone deficiency for adult bone mass. J Bone Miner Res 1994:9: 1319-1326.
23. Katzman DK, Bachrach LK, Carter DR, Marcus R: Clinical and anthropometric correlates ofbone mineral acquisition in healthy adolescent girls. J Clin Endocrinol Metab 1991:73: 1332-1339.
24. Carter DR, Bouxsein ML, Marcus R: New approaches for interpreting projected bone densitometry data. J Bone Min Res 1992:7: 137-145.
25. Homes SJ, Whitehouse RW, Swindell R, Econ-omous G, Adams JE, Shalct SM: Effect of growth hormone replacement on bone mass in adults with adult onset growth hormone deficiency. Clin Endocrinol 1995;42:627-633.
26. Degcrblad M, Elgindv N, Hall K, Sjoberg HE, Thoren M: Potent effect of recombinant growth hormone on bone mineral density and body composition in adults with panhypopituitarism. Acta Endocrinol (Copenh) 1992; 126: 387-393.
27. Vanderweghe M, Taelman P, Kaufman JM: Short and long-term effects of growth hormone treatment on bone turnover and bone mineral content in adult growlh hormone-deficient males. Clin Endocrinol (Oxford) 1993:39:409-415.
28. Baum HBA, Biller BMK, Finkelstein JS, Can-nistraro KB, Oppenheim DS, Schocnfcld DA. Michel TH. Wittink H, Klibanski A: Effects of physiologic growth hormone therapy on bone density and body composition in patients with adult onset growlh hormone deficiency. A randomized. placebo-controlled trial. Ann Int Med 1997:125:883-890.
29. Aloia JF, Zanzi I, Ellis K, Jowsey J: Effects of growth hormone in osteoporosis. J Clin Endocrinol Metab 1976;43:992-999.
30. Aloia JF, Vaswani A, Kapoor A, Yell JK, Cohn SH: Treatment of osteoporosis with calcitonin, with and without growth hormone. Metabolism 1985:34:124-129.
31. Marcus R. Butterfield G, Holloway L, Gilliland L, Baylink DJ. Hintz RL, Sherman BE: Effects of short-term administration of recombinant human growth hormone to elderly people. J Clin Endocrinol Metab 1990:70:519-527.
32. Brixca K, Nielsen HK, Nosekilde L, Flyvbjerg A: A short course of recombinant human growth hormone treatment stimulates osteoblasts and activates bone remodelling in normal human volunteers. J Bone Min Res 1990: 5:609-618.
33. Rudman D, Feller AG, Nagraj HS, Gergans GA, Lalitha PY, Goldberg AF, Schlenker RA, Cohn L, Rudman IW, Mattson DE: Effects of human growth hormone in men over 60 years old. N Engl J Med 1990:323:1-6.
34. Papadakis MA, Grady D, Black D, Tierney MJ, Gooding GAW. Schambelan M. Grunfeld C: Growth hormone replacement in healthy older men improves body composition but not functional ability. Ann Intern Med 1996:124: 708-716.
35. Holloway L, Butterfield G, Hintz RL, Gesundheit N, Marcus R: Effect of recombinant human growth hormone on metabolic indices, body composition, and bone turnover in healthy elderly women. J Clin Endocrinol Metab 1994:79:470-479.
36. Holloway L, Kohlmeier L, Kent K, Marcus R: Skeletal effects of cyclic recombinant human growth hormone and salmon calcitonin in os-teopenic postmenopausal women. J Clin Endocrinol Metab 1997;82:111-117.
37. Ebcling PR, Jones JD, O’Fallon WM, Janes CH, Riggs BL: Short-term effects of recombinant human insulin-like growth factor-1 on bone iumover in normal women. J Clin Endocr Metab 1993:77:1384-1387.
38. Ghiron L, Thompson JL, Holloway L, Hintz RL, Butterfield GE, Hoffman AR, Marcus R: Effects of recombinant insulin-like growth factor-1 and growth hormone on bone turnover in elderly women. J Bone Min Res 1995:10:1844-1852.